Related references
Note: Only part of the references are listed.Estrogen Receptor-Related Receptor α Mediates Up-Regulation of Aromatase Expression by Prostaglandin E2 in Prostate Stromal Cells
Lin Miao et al.
MOLECULAR ENDOCRINOLOGY (2010)
Estrogen receptor-β activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFα mediated
Stephen J. McPherson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Serum sex steroids, gonadotrophins and sex hormone-binding globulin in prostatic hyperplasia
Mohammad AbdulJalil Ansari et al.
ANNALS OF SAUDI MEDICINE (2009)
17β-Estradiol at Low Concentrations Acts through Distinct Pathways in Normal Versus Benign Prostatic Hyperplasia-Derived Prostate Stromal Cells
Irwin I. Park et al.
ENDOCRINOLOGY (2009)
A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia
Paloma Alonso-Magdalena et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia
J. Hammarsten et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2009)
Effect of selective estrogen receptor modulators on cell proliferation and estrogen receptor activities in normal human prostate stromal and epithelial cells
H. Nomura et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2009)
Serum Steroid and Sex Hormone-Binding Globulin Concentrations and the Risk of Incident Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial
Alan R. Kristal et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
5α-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction
Roger S. Rittmaster
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Expression of steroidogenic enzymes and sex-steroid receptors in human prostate
Georges Pelletier
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen
Clement K. M. Ho et al.
JOURNAL OF ENDOCRINOLOGY (2008)
The proliferative effect of estradiol on human prostate stromal cells is mediated through activation of ERK
Zhisong Zhang et al.
PROSTATE (2008)
Prostate stem cells and benign prostatic hyperplasia
John T. Isaacs
PROSTATE (2008)
Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2
Quan Wu et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone
Emily B. Askew et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III)
Sabine Rohrmann et al.
UROLOGY (2007)
The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay
Mary Szatkowski Ozers et al.
BIOCHEMISTRY (2007)
Prostatic stromal cells derived from benign prostatic hyperplasia specimens possess stem cell like property
Victor K. Lin et al.
PROSTATE (2007)
Calculated free testosterone in men: comparison of four equations and with free androgen index
Clement K. M. Ho et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2006)
Expression of enzymes involved in estrogen metabolism in human prostate
Yasukazu Takase et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2006)
Effect of increasing ratio of estrogen: Androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaP
KJ King et al.
PROSTATE (2006)
The identification and simultaneous quantification of 7-hydroxylated metabolites of pregnenolone, dehydroepiandrosterone, 3β,17β-androstenediol, and testosterone in human serum using gas chromatography-mass spectrometry
M Hill et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Chemistry and structural biology of androgen receptor
WQ Gao et al.
CHEMICAL REVIEWS (2005)
Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5α-reductase inhibitor
RV Clark et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men
PD Morris et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Induction of apoptosis in human prostate stromal cells by 4-hydroxytamoxifen:: an alternative therapy for benign prostate hyperplasia
W Glienke et al.
WORLD JOURNAL OF UROLOGY (2004)
Androgen receptor protein expression in prostatic tissues in black and Caucasian men
EO Olapade-Olaopa et al.
PROSTATE (2004)
CYP7B generates a selective estrogen receptor β agonist in human prostate
C Martin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Serum sex hormones and measures of benign prostatic hyperplasia
RO Roberts et al.
PROSTATE (2004)
Messenger RNA levels and enzyme activities of 5 alpha-reductase types 1 and 2 in human benign prostatic hyperplasia (BPH) tissue
T Shirakawa et al.
PROSTATE (2004)
Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor
H Fang et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2003)
Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia
AP Berger et al.
PROSTATE (2003)
Regulation of testicular function in men: implications for male hormonal contraceptive development
JK Amory et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Zone-dependent expression of estrogen receptors α and β in human benign prostatic hyperplasia
T Tsurusaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
CG Roehrborn et al.
UROLOGY (2002)
Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia
G Bartsch et al.
WORLD JOURNAL OF UROLOGY (2002)
Herbal medications in the treatment of benign prostatic hyperplasia (BPH)
E Fagelman et al.
UROLOGIC CLINICS OF NORTH AMERICA (2002)
The putative androgen receptor-A form results from in vitro proteolysis
CW Gregory et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2001)
A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the human genome project
S Sebastian et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Estrogen receptor β expression in human prostate tissue
D Pasquali et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Effects of androgen deficiency and replacement on prostate zonal volumes
B Jin et al.
CLINICAL ENDOCRINOLOGY (2001)
Estrogen receptors α and β in the normal, hyperplastic and carcinomatous human prostate
M Royuela et al.
JOURNAL OF ENDOCRINOLOGY (2001)
Longitudinal effects of aging on serum total and free testosterone levels in healthy men
SM Harman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
An estrogen receptor β isoform that lacks exon 5 has dominant negative activity on both ERα and ERβ
S Inoue et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Identification and characterization of estrogen receptor variants in prostate cancer cell lines
QN Ye et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2000)
Intracrinology:: role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease
F Labrie et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2000)
Estrogen receptor interaction with co-activators and co-repressors
CM Klinge
STEROIDS (2000)
Polymorphisms in the vitamin D receptor gene and the androgen receptor gene and the risk of benign prostatic hyperplasia
JT Bousema et al.
EUROPEAN UROLOGY (2000)
Differential regulation of testosterone vs. 5 alpha-dihydrotestosterone by selective androgen response elements
PW Hsiao et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2000)
Share Paper
